Novo Nordisk makes a bold $9 billion bid to acquire Metsera, challenging Pfizer's earlier $4.9 billion deal and intensifying the race for dominance in the lucrative obesity drug market.
Massive protests by Ultra-Orthodox Jews in Jerusalem against Israel's efforts to end their military service exemption, sparking political turmoil and clashes with police.
Novo Nordisk makes a bold $9 billion bid to acquire Metsera, challenging Pfizer's earlier $4.9 billion deal and intensifying the race for dominance in the lucrative obesity drug market.
Massive protests by Ultra-Orthodox Jews in Jerusalem against Israel's efforts to end their military service exemption, sparking political turmoil and clashes with police.